369 related articles for article (PubMed ID: 19729486)
1. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice.
Li J; Qu X; Bertram JF
Am J Pathol; 2009 Oct; 175(4):1380-8. PubMed ID: 19729486
[TBL] [Abstract][Full Text] [Related]
2. Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy.
Li J; Qu X; Yao J; Caruana G; Ricardo SD; Yamamoto Y; Yamamoto H; Bertram JF
Diabetes; 2010 Oct; 59(10):2612-24. PubMed ID: 20682692
[TBL] [Abstract][Full Text] [Related]
3. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
[TBL] [Abstract][Full Text] [Related]
4. Mangiferin Alleviates Renal Interstitial Fibrosis in Streptozotocin-Induced Diabetic Mice through Regulating the PTEN/PI3K/Akt Signaling Pathway.
Song Y; Liu W; Tang K; Zang J; Li D; Gao H
J Diabetes Res; 2020; 2020():9481720. PubMed ID: 32076626
[TBL] [Abstract][Full Text] [Related]
5. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition.
Zeisberg EM; Potenta SE; Sugimoto H; Zeisberg M; Kalluri R
J Am Soc Nephrol; 2008 Dec; 19(12):2282-7. PubMed ID: 18987304
[TBL] [Abstract][Full Text] [Related]
6. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
[TBL] [Abstract][Full Text] [Related]
7. Hedgehog Interacting Protein Promotes Fibrosis and Apoptosis in Glomerular Endothelial Cells in Murine Diabetes.
Zhao XP; Chang SY; Liao MC; Lo CS; Chenier I; Luo H; Chiasson JL; Ingelfinger JR; Chan JSD; Zhang SL
Sci Rep; 2018 Apr; 8(1):5958. PubMed ID: 29654303
[TBL] [Abstract][Full Text] [Related]
8. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse.
Wu Z; Yang L; Cai L; Zhang M; Cheng X; Yang X; Xu J
Respir Res; 2007 Jan; 8(1):1. PubMed ID: 17207287
[TBL] [Abstract][Full Text] [Related]
9. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
[No Abstract] [Full Text] [Related]
10. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
11. Endoglin Promotes Myofibroblast Differentiation and Extracellular Matrix Production in Diabetic Nephropathy.
Gerrits T; Zandbergen M; Wolterbeek R; Bruijn JA; Baelde HJ; Scharpfenecker M
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081058
[TBL] [Abstract][Full Text] [Related]
12. KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis.
Huang C; Shen S; Ma Q; Gill A; Pollock CA; Chen XM
Nephrol Dial Transplant; 2014 Feb; 29(2):313-24. PubMed ID: 24166472
[TBL] [Abstract][Full Text] [Related]
13. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
[TBL] [Abstract][Full Text] [Related]
14. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis.
Wang SN; Hirschberg R
Am J Physiol Renal Physiol; 2000 Apr; 278(4):F554-60. PubMed ID: 10751215
[TBL] [Abstract][Full Text] [Related]
15. Transformation of interstitial fibroblasts and tubulointerstitial fibrosis in diabetic nephropathy.
Ina K; Kitamura H; Tatsukawa S; Takayama T; Fujikura Y; Shimada T
Med Electron Microsc; 2002 Jun; 35(2):87-95. PubMed ID: 12181650
[TBL] [Abstract][Full Text] [Related]
16. Myofibroblast phenotypes expression in experimental renal scarring.
Muchaneta-Kubara EC; el Nahas AM
Nephrol Dial Transplant; 1997 May; 12(5):904-15. PubMed ID: 9175042
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-to-Myofibroblast Transition Contributes to Interstitial Fibrosis in Chronic Renal Allograft Injury.
Wang YY; Jiang H; Pan J; Huang XR; Wang YC; Huang HF; To KF; Nikolic-Paterson DJ; Lan HY; Chen JH
J Am Soc Nephrol; 2017 Jul; 28(7):2053-2067. PubMed ID: 28209809
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
Wang Y; Lin C; Ren Q; Liu Y; Yang X
Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
[TBL] [Abstract][Full Text] [Related]
19. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
[TBL] [Abstract][Full Text] [Related]
20. Roscovitine attenuates renal interstitial fibrosis in diabetic mice through the TGF-β1/p38 MAPK pathway.
Wang S; Zhou Y; Zhang Y; He X; Zhao X; Zhao H; Liu W
Biomed Pharmacother; 2019 Jul; 115():108895. PubMed ID: 31029000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
